Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

ProMIS Neurosciences

Tracked across 4 events · 27 articles · First seen Jul 14, 2026 · Last active Sep 01, 2026

Sentiment
20
Attention
3
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
3 60
Tech
Impact: ProMIS Neurosciences is the developer of PMN310; positive Phase 1a data supports its precision medicine approach and may enhance its valuation.
Jul 14, 2026 · 6 articles
2 10
Tech
Impact: ProMIS is hosting the webinar to discuss its lead candidate PMN310; the event is central to its clinical development.
Jul 27, 2026 · 6 articles
0 0
Business
Impact: ProMIS Neurosciences is the subject of the announcement, which details its upcoming Q2 2026 financial results and business update. The event is a routine disclosure that may affect investor perception based on the reported results and strategic updates.
Aug 03, 2026 · 7 articles
1 10
Business
Impact: ProMIS is the central entity, announcing its participation in multiple conferences to showcase its pipeline and clinical progress. The events provide a platform to communicate its EpiSelect platform and PMN310 trial data, potentially influencing investor perception.
Sep 01, 2026 · 8 articles
ERGEN INTELLIGENCE
Track ProMIS Neurosciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.